Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma

被引：46

作者：

Ayuk, F

Shimoni, A

Nagler, A

Schwerdtfeger, R

Kiehl, M

Sayer, HG

Zabelina, T

Zander, AR

Kröger, N

机构：

[1] Univ Hamburg, Hosp Eppendorf, Dept Bone Marrow Transplantat, D-20246 Hamburg, Germany

[2] Chaim Sheba Med Ctr, Dept Haematol & Oncol, IL-52621 Tel Hashomer, Israel

[3] DKD Clin, Dept Bone Marrow Transplantat, Wiesbaden, Germany

[4] Bone Marrow Transplantat Clin, Idar Oberstein, Germany

[5] Univ Jena, Dept Haematol & Oncol, D-6900 Jena, Germany

来源：

LEUKEMIA | 2004年 / 18卷 / 03期

关键词：

D O I：

10.1038/sj.leu.2403252

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：659 / 662

页数：5

共 9 条

[1] Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
Dazzi, F
Szydlo, RM
Craddock, C
Cross, NCP
Kaeda, J
Chase, A
Olavarria, E
van Rhee, F
Kanfer, E
Apperley, JF
Goldman, JM
[J]. BLOOD, 2000, 95 (01) : 67 - 71
[2] Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma:: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres
Gahrton, G
Svensson, H
Cavo, M
Apperley, J
Bacigalupo, A
Björkstrand, B
Bladé, J
Cornelissen, J
de Laurenzi, A
Facon, T
Ljungman, P
Michallet, M
Niederwieser, D
Powles, R
Reiffers, J
Russell, NH
Samson, D
Schaefer, UW
Schattenberg, A
Tura, S
Verdonck, LF
Vernant, JP
Willemze, R
Volin, L
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (01) : 209 - 216
[3] Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
Giralt, S
Thall, PF
Khouri, I
Wang, XM
Braunschweig, I
Ippolitti, C
Claxton, D
Donato, M
Bruton, J
Cohen, A
Davis, M
Andersson, BS
Anderlini, P
Gajewski, J
Kornblau, S
Andreeff, M
Przepiorka, D
Ueno, NT
Molldrem, J
Champlin, R
[J]. BLOOD, 2001, 97 (03) : 631 - 637
[4] GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS
KOLB, HJ
SCHATTENBERG, A
GOLDMAN, JM
HERTENSTEIN, B
JACOBSEN, N
ARCESE, W
LJUNGMAN, P
FERRANT, A
VERDONCK, L
NIEDERWIESER, D
VANRHEE, F
MITTERMUELLER, J
DEWITTE, T
HOLLER, E
ANSARI, H
[J]. BLOOD, 1995, 86 (05) : 2041 - 2050
[5] Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma
Kröger, N
Schwerdtfeger, R
Kiehl, M
Sayer, HG
Renges, H
Zabelina, T
Fehse, B
Tögel, F
Wittkowsky, G
Kuse, R
Zander, AR
[J]. BLOOD, 2002, 100 (03) : 755 - 760
[6] Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome
Lokhorst, HM
Schattenberg, A
Cornelissen, JJ
van Oers, MHJ
Fibbe, W
Russell, I
Van der Donk, NWCJ
Verdonck, LF
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 3031 - 3037
[7] ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE
MACKINNON, S
PAPADOPOULOS, EB
CARABASI, MH
REICH, L
COLLINS, NH
BOULAD, F
CASTROMALASPINA, H
CHILDS, BH
GILLIO, AP
KERNAN, NA
SMALL, TN
YOUNG, JW
OREILLY, RJ
[J]. BLOOD, 1995, 86 (04) : 1261 - 1268
[8] The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation
Marks, DI
Lush, R
Cavenagh, J
Milligan, DW
Schey, S
Parker, A
Clark, FJ
Hunt, L
Yin, J
Fuller, S
Vandenberghe, E
Marsh, J
Littlewood, T
Smith, GM
Culligan, D
Hunter, A
Chopra, R
Davies, A
Towlson, K
Williams, CD
[J]. BLOOD, 2002, 100 (09) : 3108 - 3114
[9] Graft-versus-myeloma effect: Proof of principle
Tricot, G
Vesole, DH
Jagannath, S
Hilton, J
Munshi, N
Barlogie, B
[J]. BLOOD, 1996, 87 (03) : 1196 - 1198

← 1 →